Ayanna Walden
West Hollywood, CANPI 1316958028
Payments from drug & device makers
$2,049in general payments, 2019–2025
Across 102 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$567
- Therapeuticsmd, Inc.$328
- Organon$163
- Agile Therapeutics, Inc.$132
- Evofem Biosciences, Inc.$132
- Pfizer$115
- plus $612 from 16 others
What the payments were for
- Food & beverage$2,00698%
- Education$432%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
24
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 27 | $567 |
| Therapeuticsmd, Inc. | 21 | $328 |
| Organon | 3 | $163 |
| Agile Therapeutics, Inc. | 6 | $132 |
| Evofem Biosciences, Inc. | 11 | $132 |
| Pfizer | 5 | $115 |
| Mayne Pharma Commercial LLC | 4 | $98 |
| Bayer | 3 | $71 |
| Exeltis, USA Inc. | 3 | $66 |
| Lupin Inc. | 4 | $61 |
| Shield Therapeutics Inc | 2 | $45 |
| Scynexis, Inc. | 2 | $44 |
| AMAG Pharmaceuticals, Inc. | 2 | $43 |
| BD | 1 | $35 |
| Hologic Sales And Service, LLC | 1 | $29 |
| Duchesnay USA Incorporated | 1 | $23 |
| Gilead | 1 | $19 |
| Merck | 1 | $19 |
| Avion Pharmaceuticals | 1 | $18 |
| Aspira Women's Health Inc | 1 | $16 |
| Myovant Sciences Inc. | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.